Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Johnson & Johnson
SymbolNYSE:JNJ
Price Information
Current Price$162.69
52 Week RangeBuy
MarketRank™
Overall Score2.7
Analysis Score3.4
Community Score2.5
Dividend Score4.2
Ownership Score1.7
Earnings & Valuation Score1.9
Analyst Ratings
Consensus RecommendationBuy
Consensus Price Target$182.62
% Upside from Price Target12.25% upside
Trade Information
Market Cap$428.32 billion
Beta0.7
Average Volume8,234,238
Sales & Book Value
Annual Revenue$82.06 billion
Price / Sales5.22
Cashflow$11.87 per share
Price / Cash13.71
Book Value$22.60 per share
Price / Book7.20
Profitability
Net Income$15.12 billion
EPS$8.68
Trailing P/E Ratio25.58
Forward P/E Ratio18.30
P/E Growth3.06
Net Margins21.01%
Return on Equity (ROE)34.64%
Return on Assets (ROA)13.40%
Dividend
Annual Payout$4.04
Dividend Yield2.48%
Three-Year Dividend Growth19.88%
Payout Ratio46.54%
Years of Consecutive Dividend Growth59 Years
Debt
Debt-to-Equity Ratio0.51%
Current Ratio1.48%
Quick Ratio1.24%
Ownership Information
Institutional Ownership Percentage67.25%
Insider Ownership Percentage0.27%
Miscellaneous
Employees134,500
Shares Outstanding2.63 billion
Next Earnings Date4/20/2021 (Confirmed)
OptionableOptionable
SourceHeadline
Many global stocks lower after Wall St. declineMany global stocks lower after Wall St. decline
marketbeat.com - April 20 at 5:21 AM
California counties seek billions from drugmakers in opioid trialCalifornia counties seek billions from drugmakers in opioid trial
ft.com - April 20 at 12:45 AM
Asian stock markets mixed after Wall St declineAsian stock markets mixed after Wall St decline
marketbeat.com - April 20 at 12:29 AM
The Latest: Schools reopen in Mexicos Campeche stateThe Latest: Schools reopen in Mexico's Campeche state
marketbeat.com - April 19 at 10:31 PM
Philippines approves emergency use of J&J, Bharat BiotechCOVID-19 vaccinesPhilippines approves emergency use of J&J, Bharat BiotechCOVID-19 vaccines
finance.yahoo.com - April 19 at 10:23 PM
Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings?Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings?
in.finance.yahoo.com - April 19 at 5:23 PM
Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gainsJohnson & Johnson stock underperforms Monday when compared to competitors despite daily gains
msn.com - April 19 at 5:23 PM
What does a strong reaction to a COVID-19 vaccine mean?What does a strong reaction to a COVID-19 vaccine mean?
finance.yahoo.com - April 19 at 5:23 PM
Gold prices end lower after biggest weekly rise since DecemberGold prices end lower after biggest weekly rise since December
finance.yahoo.com - April 19 at 5:23 PM
Emergent Plummets as FDA Inspects J&J Vaccine Production SiteEmergent Plummets as FDA Inspects J&J Vaccine Production Site
finance.yahoo.com - April 19 at 5:23 PM
Emergent BioSolutions Stock Falls After FDA Initiates Inspection Of Bayview FacilityEmergent BioSolutions Stock Falls After FDA Initiates Inspection Of Bayview Facility
benzinga.com - April 19 at 1:45 PM
Thinking about trading options or stock in Coca-Cola, First Solar, Corning, Johnson & Johnson, or General Electric?Thinking about trading options or stock in Coca-Cola, First Solar, Corning, Johnson & Johnson, or General Electric?
marketwatch.com - April 19 at 12:23 PM
Decision On Resuming Johnson & Johnson Vaccine Expected This WeekDecision On Resuming Johnson & Johnson Vaccine Expected This Week
markets.businessinsider.com - April 19 at 12:23 PM
How to Trade Johnson & Johnson After It Reports EarningsHow to Trade Johnson & Johnson After It Reports Earnings
thestreet.com - April 19 at 12:23 PM
Gold prices pull back after biggest weekly rise since DecemberGold prices pull back after biggest weekly rise since December
finance.yahoo.com - April 19 at 12:23 PM
South Africas vaccine compensation fund could cost $17.5 mln in first yearSouth Africa's vaccine compensation fund could cost $17.5 mln in first year
finance.yahoo.com - April 19 at 12:23 PM
U.S. agency reviewing potential additional cases of severe side effects linked to J&J shot - CDCU.S. agency reviewing potential additional cases of severe side effects linked to J&J shot - CDC
finance.yahoo.com - April 19 at 12:23 PM
Doctor on J&J vaccine: It comes down to the benefit-risk ratioDoctor on J&J vaccine: It comes down to 'the benefit-risk ratio'
finance.yahoo.com - April 19 at 12:23 PM
2 Things Investors Need to Look For in Johnson & Johnsons Earnings Tomorrow2 Things Investors Need to Look For in Johnson & Johnson's Earnings Tomorrow
finance.yahoo.com - April 19 at 12:23 PM
Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says theyre wrong. - CNN Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says they're wrong. - CNN
news.google.com - April 19 at 12:18 PM
Dr. Fauci Says This is a "Red Flag" After Your Vaccine - msnNOWDr. Fauci Says This is a "Red Flag" After Your Vaccine - msnNOW
news.google.com - April 19 at 12:18 PM
The Margin: Johnson & Johnson vaccine pause: What to know if you got or scheduled the shotThe Margin: Johnson & Johnson vaccine pause: What to know if you got or scheduled the shot
marketwatch.com - April 19 at 11:32 AM
Johnson & Johnson Reports Earnings Tuesday. Here’s What to Expect.Johnson & Johnson Reports Earnings Tuesday. Here’s What to Expect.
barrons.com - April 19 at 10:56 AM
Johnson & Johnson (JNJ Stock) should continue with the rally this week after rebounceJohnson & Johnson (JNJ Stock) should continue with the rally this week after rebounce
fxstreet.com - April 19 at 7:22 AM
J&J, other drugmakers to face trial in California over claims they fueled opioid epidemicJ&J, other drugmakers to face trial in California over claims they fueled opioid epidemic
finance.yahoo.com - April 19 at 7:22 AM
Emergent BioSolutions says it has agreed with FDA not to manufacture new material at Baltimore facilityEmergent BioSolutions says it has agreed with FDA not to manufacture new material at Baltimore facility
finance.yahoo.com - April 19 at 7:22 AM
UPDATE 2-FDA tells Emergent plant behind botched COVID-19 vaccines to stop manufacturingUPDATE 2-FDA tells Emergent plant behind botched COVID-19 vaccines to stop manufacturing
finance.yahoo.com - April 19 at 7:22 AM
Global shares mixed amid cautious outlook for global economyGlobal shares mixed amid cautious outlook for global economy
marketbeat.com - April 19 at 5:46 AM
The Latest: EU to purchase 100 million more vaccine dosesThe Latest: EU to purchase 100 million more vaccine doses
marketbeat.com - April 19 at 4:59 AM
Fauci Predicts Johnson & Johnson Vaccine Will Be Reapproved This Week - HuffPostFauci Predicts Johnson & Johnson Vaccine Will Be Reapproved This Week - HuffPost
news.google.com - April 18 at 10:45 PM
Source: Swiss billionaire drops bid for Tribune Publishing Source: Swiss billionaire drops bid for Tribune Publishing
marketbeat.com - April 18 at 4:00 PM
The Latest: Vaccines to be made available at Alaska airportsThe Latest: Vaccines to be made available at Alaska airports
marketbeat.com - April 16 at 9:11 PM
The Latest: New COVID-19 cases rising again in New MexicoThe Latest: New COVID-19 cases rising again in New Mexico
marketbeat.com - April 16 at 6:49 PM
 S&P 500 hits another record, marks 4th weekly gain in a row S&P 500 hits another record, marks 4th weekly gain in a row
marketbeat.com - April 16 at 4:17 PM
The Latest: Michigan extends pandemic order amid high casesThe Latest: Michigan extends pandemic order amid high cases
marketbeat.com - April 16 at 3:52 PM
Germans IDT to make 10M AstraZeneca vaccine doses in 2021German's IDT to make 10M AstraZeneca vaccine doses in 2021
marketbeat.com - April 16 at 11:56 AM
The Latest: US opens more distance in worldwide vaccine raceThe Latest: US opens more distance in worldwide vaccine race
marketbeat.com - April 15 at 3:22 PM
The Latest: Pope offers Brazilians hope among soaring deathsThe Latest: Pope offers Brazilians hope among soaring deaths
marketbeat.com - April 15 at 12:58 PM
The Latest: Sweden reports 7,000 daily cases, more in youngThe Latest: Sweden reports 7,000 daily cases, more in young
marketbeat.com - April 15 at 12:42 PM
The Latest: WHO: Europe surpasses 1 million COVID-19 deathsThe Latest: WHO: Europe surpasses 1 million COVID-19 deaths
marketbeat.com - April 15 at 8:20 AM
The Latest: Serbia to produce Russias Sputnik V vaccineThe Latest: Serbia to produce Russia's Sputnik V vaccine
marketbeat.com - April 15 at 6:16 AM
The Latest: Thailand adds 1,500 cases, mulls new measuresThe Latest: Thailand adds 1,500 cases, mulls new measures
marketbeat.com - April 15 at 3:50 AM
What is a COVID-19 vaccine passport, and will I need one?What is a COVID-19 vaccine passport, and will I need one?
marketbeat.com - April 15 at 3:20 AM
The Latest: California governor says all schools must reopenThe Latest: California governor says all schools must reopen
marketbeat.com - April 14 at 7:21 PM
The Latest: Hawaii lawmakers to delay raises over pandemicThe Latest: Hawaii lawmakers to delay raises over pandemic
marketbeat.com - April 14 at 6:16 PM
The Latest: Ivanka Trump receives 1st dose of Pfizer vaccineThe Latest: Ivanka Trump receives 1st dose of Pfizer vaccine
marketbeat.com - April 14 at 5:06 PM
The Latest: Turkey posts record 62,797 daily virus casesThe Latest: Turkey posts record 62,797 daily virus cases
marketbeat.com - April 14 at 3:13 PM
Four Reasons Why Truist Financial Is a Super Bet Among Regional Banks (JNJ)Four Reasons Why Truist Financial Is a Super Bet Among Regional Banks (JNJ)
marketbeat.com - April 14 at 2:54 PM
The Latest: US weighs next steps for J&J coronavirus shotThe Latest: US weighs next steps for J&J coronavirus shot
marketbeat.com - April 14 at 2:26 PM
The Latest: Italy: Additional 7M Pfizer doses by end of JuneThe Latest: Italy: Additional 7M Pfizer doses by end of June
marketbeat.com - April 14 at 1:06 PM
DateCompanyBrokerageAction
1/27/2021Johnson & JohnsonJPMorgan Chase & Co.Boost Price Target
1/27/2021Johnson & JohnsonCredit Suisse GroupBoost Price Target
1/27/2021Johnson & JohnsonRaymond JamesBoost Price Target
1/27/2021Johnson & JohnsonCowenBoost Price Target
1/27/2021Johnson & JohnsonMorgan StanleyBoost Price Target
1/27/2021Johnson & JohnsonSVB LeerinkBoost Price Target
1/27/2021Johnson & JohnsonWells Fargo & CompanyBoost Price Target
1/26/2021Johnson & JohnsonCantor FitzgeraldBoost Price Target
8/19/2020Johnson & JohnsonStifel NicolausDowngrade
7/20/2020Johnson & JohnsonBank of AmericaReiterated Rating
7/20/2020Johnson & JohnsonIndependent ResearchUpgrade
7/17/2020Johnson & JohnsonCitigroupBoost Price Target
4/29/2020Johnson & JohnsonBarclaysBoost Price Target
(Data available from 4/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.